Updates are available Correction dated 2022-03-07
Click to view Correction: https://doi.org/10.1007/s00259-022-05755-3
-
Authors
Guedj, Eric http://orcid.org/0000-0003-1912-6132
Varrone, Andrea
Boellaard, Ronald
Albert, Nathalie L.
Barthel, Henryk
van Berckel, Bart
Brendel, Matthias
Cecchin, Diego
Ekmekcioglu, Ozgul
Garibotto, Valentina
Lammertsma, Adriaan A.
Law, Ian
Peñuelas, Iván
Semah, Franck
Traub-Weidinger, Tatjana
van de Giessen, Elsmarieke
Van Weehaeghe, Donatienne
Morbelli, Silvia
- License Information
-
More Information
Article History
Received: 10 September 2021
Accepted: 21 October 2021
First Online: 9 December 2021
Change Date: 7 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00259-022-05755-3
Declarations
:
: Not applicable.
: Not applicable.
: BvB received research support from ZON-MW, AVID radiopharmaceuticals, CTMM, IXICO, Springer and Janssen Pharmaceuticals. He is a trainer for Piramal and GE. He receives no personal honoraria.EG has received consultant and speaker honoraria from GE Healthcare and CIS Bio International; and consultant honoraria from Advanced Accelerator Applications.HB has received speaker honoraria from AAA/Novartis.IL has received speaker honoraria from Siemens Healthcare.MB has received speaker honoraria from GE healthcare, Roche, and LMI and is an advisor of LMI.SM has received speaker honoraria from GE Healthcare and Advanced Accelerator Applications.VG has received research/teaching funding through her institution from Siemens Healthineers, GE Healthcare, Roche, Merck, Cerveau Technologies and Life Molecular Imaging.AV is at present employed at H. Lundbeck A/S.The other authors declare that they have no conflict of interest.
